JP2022533433A5 - - Google Patents
Info
- Publication number
- JP2022533433A5 JP2022533433A5 JP2021569359A JP2021569359A JP2022533433A5 JP 2022533433 A5 JP2022533433 A5 JP 2022533433A5 JP 2021569359 A JP2021569359 A JP 2021569359A JP 2021569359 A JP2021569359 A JP 2021569359A JP 2022533433 A5 JP2022533433 A5 JP 2022533433A5
- Authority
- JP
- Japan
- Prior art keywords
- etoh
- methanesulfonylphenoxy
- fluoro
- propyl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19176514 | 2019-05-24 | ||
| EP19176514.8 | 2019-05-24 | ||
| EP20166361 | 2020-03-27 | ||
| EP20166361.4 | 2020-03-27 | ||
| PCT/EP2020/064046 WO2020239568A1 (en) | 2019-05-24 | 2020-05-20 | Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022533433A JP2022533433A (ja) | 2022-07-22 |
| JP2022533433A5 true JP2022533433A5 (enExample) | 2023-05-29 |
| JP7623958B2 JP7623958B2 (ja) | 2025-01-29 |
Family
ID=70682855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569359A Active JP7623958B2 (ja) | 2019-05-24 | 2020-05-20 | ［２－（３－フルオロ－５－メタンスルホニルフェノキシ）エチル］（プロピル）アミンの薬学的に許容される塩、およびその使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US12275694B2 (enExample) |
| EP (2) | EP3976581B1 (enExample) |
| JP (1) | JP7623958B2 (enExample) |
| KR (1) | KR102892833B1 (enExample) |
| CN (1) | CN113853369B (enExample) |
| AU (1) | AU2020286003B2 (enExample) |
| BR (1) | BR112021023563A2 (enExample) |
| CA (1) | CA3140805A1 (enExample) |
| CL (1) | CL2021003115A1 (enExample) |
| CO (1) | CO2021016556A2 (enExample) |
| DK (1) | DK3976581T3 (enExample) |
| ES (2) | ES2970361T3 (enExample) |
| FI (1) | FI3976581T3 (enExample) |
| IL (1) | IL288271B2 (enExample) |
| JO (1) | JOP20210312A1 (enExample) |
| MX (1) | MX2021014271A (enExample) |
| PH (1) | PH12021552844A1 (enExample) |
| PL (1) | PL3976581T3 (enExample) |
| PT (1) | PT3976581T (enExample) |
| SG (1) | SG11202112165QA (enExample) |
| WO (1) | WO2020239568A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12275694B2 (en) | 2019-05-24 | 2025-04-15 | Irl 790 Ab | Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof |
| JP7688690B2 (ja) | 2020-07-28 | 2025-06-04 | スーチュアン・コールン－バイオテック・バイオファーマシューティカル・カンパニー・リミテッド | ピリミジン系化合物の塩、結晶形およびその調製方法 |
| JP2023548429A (ja) * | 2020-11-10 | 2023-11-16 | インテグレイティブ・リサーチ・ラボラトリーズ・スウェーデン・アーベー | パーキンソン病、特にｌ－ｄｏｐａ誘発性ジスキネジアのための医薬品に対する感作の予防または軽減における使用のための［２－（３－フルオロ－５－メタンスルホニルフェノキシ）エチル］（プロピル）アミン（メスドペタム） |
| WO2024042540A1 (en) * | 2022-08-24 | 2024-02-29 | Alkem Laboratories Limited | Mesdopetam compositions |
| CA3268423A1 (en) | 2022-09-21 | 2024-03-28 | Assia Chemical Industries Ltd. | Solid state forms of mesdopetam and salts thereof |
| GB202312055D0 (en) | 2023-08-07 | 2023-09-20 | Ipsen Biopharm Ltd | Pharmaceutical compositions |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS51123821A (en) | 1975-04-18 | 1976-10-28 | Nippon Kayaku Co Ltd | An algicide and protective agent |
| US4128574A (en) * | 1976-10-04 | 1978-12-05 | General Electric Company | Method for making organic polycarboxylic acids |
| GB8823405D0 (en) | 1988-10-05 | 1988-11-09 | Erba Carlo Spa | Aryloxy-arythio-heteraryloxy-heteroarylthio-alkenylene derivatives of amines |
| ES2169102T3 (es) | 1994-10-14 | 2002-07-01 | Merck Patent Gmbh | (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central. |
| SE9904723D0 (sv) * | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
| DOP2001000189A (es) | 2000-06-30 | 2002-03-30 | Pfizer Prod Inc | Benzofenonas y sulfonas como inhibidores de la captación de glicina |
| JP2006193494A (ja) | 2005-01-17 | 2006-07-27 | Dainippon Ink & Chem Inc | ４級アンモニウム系化合物を有効成分とする心臓疾患治療剤 |
| CN101203511A (zh) | 2005-06-23 | 2008-06-18 | 阿斯利康(瑞典)有限公司 | 作为神经激肽受体拮抗剂用于治疗胃肠疾病的新氮杂环丁烷衍生物 |
| WO2007063789A1 (ja) | 2005-11-29 | 2007-06-07 | Kissei Pharmaceutical Co., Ltd. | 新規なカテコール誘導体、それを含有する医薬組成物およびそれらの用途 |
| WO2007072041A1 (en) | 2005-12-23 | 2007-06-28 | Astex Therapeutics Limited | Therapeutic compounds |
| AU2007218086A1 (en) * | 2006-02-15 | 2007-08-30 | M's Science Corporation | Piperazine derivatives |
| CA2687721A1 (en) * | 2007-06-08 | 2008-12-18 | Arena Pharmaceuticals, Inc. | Crystalline forms of (r)-1-{2-[4'-(3-methoxy-propane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine, and compositions, and methods related thereto |
| TW200932225A (en) * | 2007-12-14 | 2009-08-01 | Lundbeck & Co As H | 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine |
| JP2011519839A (ja) | 2008-04-29 | 2011-07-14 | エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ | ドーパミン神経伝達のモジュレーター |
| WO2009133110A1 (en) | 2008-04-29 | 2009-11-05 | Nsab, Filial Af Neurosearch Sweden Ab, Sverige | Modulators of dopamine neurotransmission |
| MX2010011724A (es) | 2008-04-29 | 2010-11-30 | Nsab Af Neurosearch Sweden Ab | Moduladores de neurotransmision de dopamina. |
| US9006227B2 (en) * | 2011-04-19 | 2015-04-14 | Integrative Research Laboratories Sweden Ab | Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission |
| WO2016106142A1 (en) | 2014-12-22 | 2016-06-30 | Teva Pharmaceuticals International Gmbh | L-tartrate salt of pridopidine |
| MX391727B (es) | 2016-02-08 | 2025-03-21 | Merck Patent Gmbh | Modificaciones cristalinas de clorhidrato de n-(4,5-bismetansulfonil-2-metilbenzoil)guanidina y sales de n-(4,5-bismetansulfonil-2-metilbenzoil)guanidina. |
| EP3625213B1 (en) | 2017-05-19 | 2023-03-08 | Integrative Research Laboratories Sweden AB | (+)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine fumarate, a process for its preparation and uses thereof |
| SG11202000833YA (en) * | 2017-08-07 | 2020-02-27 | Suven Life Sciences Ltd | Fluoropiperidine compounds as pure 5-ht6 receptor antagonists |
| WO2020110128A1 (en) | 2018-11-29 | 2020-06-04 | Prilenia Neurotherapeutics Ltd. | Combination of pridopidine and an additional therapeutic agent for treating drug induced dyskinesia |
| US12275694B2 (en) | 2019-05-24 | 2025-04-15 | Irl 790 Ab | Pharmaceutically acceptable salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine and uses thereof |
-
2020
- 2020-05-20 US US17/612,902 patent/US12275694B2/en active Active
- 2020-05-20 PH PH1/2021/552844A patent/PH12021552844A1/en unknown
- 2020-05-20 KR KR1020217037818A patent/KR102892833B1/ko active Active
- 2020-05-20 FI FIEP20725728.8T patent/FI3976581T3/fi active
- 2020-05-20 DK DK20725728.8T patent/DK3976581T3/da active
- 2020-05-20 SG SG11202112165QA patent/SG11202112165QA/en unknown
- 2020-05-20 EP EP20725728.8A patent/EP3976581B1/en active Active
- 2020-05-20 CN CN202080036829.0A patent/CN113853369B/zh active Active
- 2020-05-20 EP EP23190702.3A patent/EP4292653B1/en active Active
- 2020-05-20 BR BR112021023563A patent/BR112021023563A2/pt unknown
- 2020-05-20 JP JP2021569359A patent/JP7623958B2/ja active Active
- 2020-05-20 PT PT207257288T patent/PT3976581T/pt unknown
- 2020-05-20 IL IL288271A patent/IL288271B2/en unknown
- 2020-05-20 PL PL20725728.8T patent/PL3976581T3/pl unknown
- 2020-05-20 AU AU2020286003A patent/AU2020286003B2/en active Active
- 2020-05-20 CA CA3140805A patent/CA3140805A1/en active Pending
- 2020-05-20 ES ES20725728T patent/ES2970361T3/es active Active
- 2020-05-20 WO PCT/EP2020/064046 patent/WO2020239568A1/en not_active Ceased
- 2020-05-20 MX MX2021014271A patent/MX2021014271A/es unknown
- 2020-05-20 ES ES23190702T patent/ES3072819T3/es active Active
-
2021
- 2021-11-24 JO JOP/2021/0312A patent/JOP20210312A1/ar unknown
- 2021-11-24 CL CL2021003115A patent/CL2021003115A1/es unknown
- 2021-12-06 CO CONC2021/0016556A patent/CO2021016556A2/es unknown
-
2025
- 2025-03-14 US US19/080,430 patent/US20250243155A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101874016B (zh) | 2-羟基-5-苯基烷基氨基苯甲酸衍生物及其盐的生产方法 | |
| JP2012500819A5 (enExample) | ||
| JP6228210B2 (ja) | フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法 | |
| CN102452972B (zh) | 一种制备奥拉西坦化合物的方法 | |
| JP6592085B2 (ja) | レバプラザン塩酸塩の調製方法 | |
| CN102424659A (zh) | 一种对甲砜基苯丝氨酸乙酯的合成方法 | |
| JP7379470B2 (ja) | レンバチニブの調製方法 | |
| JP2010510253A5 (enExample) | ||
| CN102351858B (zh) | 一种高选择性合成莫西沙星的方法 | |
| TW212181B (enExample) | ||
| CN117466867B (zh) | 一种合成沃诺拉赞的新工艺及其应用 | |
| CN101717370A (zh) | 一种制备2-正丙基-4-甲基-6-(1-甲基苯并咪唑-2-基)苯并咪唑的新方法 | |
| JP2010502682A5 (enExample) | ||
| JPS5821658B2 (ja) | エンキセイオキサジンセンリヨウノセイホウ | |
| CN110256411B (zh) | 一种2，3-二取代苯并-γ-吡喃酮衍生物的制备方法 | |
| CN110003119A (zh) | 一种5-甲基-5-苯基巴比妥酸的制备方法 | |
| CN101921194A (zh) | 一种制备4-氯二苯甲胺的方法 | |
| CN103408544A (zh) | 一种黄藤素的制备方法 | |
| JP6284942B2 (ja) | ４−アミノ−２，５−ジメトキシピリミジンから２−アミノ−５，８−ジメトキシ［１，２，４］トリアゾロ［１，５−ｃ］ピリミジンを調製するための改善された方法 | |
| CN108276331A (zh) | 一种诺氟沙星的制备方法及其精制工艺 | |
| CN104230739B (zh) | 用均苯三甲酸生产n, nˊ,nˊˊ-三环己基-1,3,5-苯酰胺的工艺 | |
| JP2003201281A (ja) | ４−（２−メチル−１−イミダゾリル）−２，２−ジフェニルブタンアミドの製造方法 | |
| CN105294697B (zh) | 2-氨基-5,8-二甲氧基[1,2,4]三唑并[1,5-c]嘧啶的合成方法 | |
| CN119431326B (zh) | 一种匹莫苯丹的合成方法 | |
| JP7683005B2 (ja) | Ｐｉ３ｋ阻害剤としての化合物の製造方法及びその製造のための中間体化合物 |